Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
Roldan Munoz, Sonia, Postmus, Douwe, de Vries, Sieta T, Arnardottir, Arna H, Dolu, İlknur, Hillege, Hans, Mol, Peter G M
Published in Frontiers in pharmacology (25.02.2021)
Published in Frontiers in pharmacology (25.02.2021)
Get full text
Journal Article
Understanding drug preferences, different perspectives
Mol, Peter G. M., Arnardottir, Arna H., Straus, Sabine M. J., Graeff, Pieter A., Haaijer‐Ruskamp, Flora M., Quik, Elise H., Krabbe, Paul F. M., Denig, Petra
Published in British journal of clinical pharmacology (01.06.2015)
Published in British journal of clinical pharmacology (01.06.2015)
Get full text
Journal Article
Post-Approval Safety Issues with Innovative Drugs: A European Cohort Study
Mol, Peter G. M., Arnardottir, Arna H., Motola, Domenico, Vrijlandt, Patrick J., Duijnhoven, Ruben G., Haaijer-Ruskamp, Flora M., de Graeff, Pieter A., Denig, Petra, Straus, Sabine M. J. M.
Published in Drug safety (01.11.2013)
Published in Drug safety (01.11.2013)
Get full text
Journal Article
Effect of Safety Issues with HIV Drugs on the Approval Process of Other Drugs in the Same Class: An Analysis of European Public Assessment Reports
Arnardottir, Arna H., Haaijer-Ruskamp, Flora M., Straus, Sabine M. J., de Graeff, Pieter A., Mol, Peter G. M.
Published in Drug safety (01.11.2011)
Published in Drug safety (01.11.2011)
Get full text
Journal Article